2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$17.16-$0.02 (-0.11%)
Price as of Jul 14, 2026 4:01 AM EDT- $5.5BMarket Cap
- 104.04%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$17.16-$0.02 (-0.11%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.18 | ||
Change | +$0.17 (+1.00%) | ||
Open | $16.85 | ||
High | $17.34 | ||
Low | $16.82 | ||
Previous Close | $17.01 | ||
Volume | 3,009,907 | ||
30-Day Average Volume | 2,345,953 | ||
1-Week Change | 1.54% | ||
1-Month Change | 6.05% | ||
1-Year Change | 104.04% | ||
3-Year Change | 465.13% | ||
5-Year Change | 267.09% | ||
Fundamentals | |||
Shares Outstanding | 319.3M | ||
Total Assets | $3.5B | ||
Market Cap | $5.5B | ||
Enterprise Value | $7.9B | ||
Period: QTR TTM FY | |||
Revenue | $722.5M | ||
Net Income | $62.3M | ||
Free Cash Flow | -$34.9M | ||
EBIT | $117.8M | ||
EBITDA | $147.8M | ||
Net Working Capital | $1.1B | ||
EPS | $0.19 | ||
Enterprise Value/EBITDA | 53 | ||
Enterprise Value/Revenue | 11 | ||
P/B | -121 | ||
P/E | 90 | ||
PEG | 1 | ||
Price/Free Cash Flow | -157 | ||
Price/Operating Cash Flow | -205 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue